183 related articles for article (PubMed ID: 28214565)
1. Trends and outcomes of cardiac resynchronization therapy upgrade procedures: A comparative analysis using a United States National Database 2003-2013.
Cheung JW; Ip JE; Markowitz SM; Liu CF; Thomas G; Feldman DN; Swaminathan RV; Lerman BB; Kim LK
Heart Rhythm; 2017 Jul; 14(7):1043-1050. PubMed ID: 28214565
[TBL] [Abstract][Full Text] [Related]
2. Impact of institutional procedural volume on inhospital outcomes after cardiac resynchronization therapy device implantation: US national database 2003-2011.
Yeo I; Kim LK; Lerman BB; Cheung JW
Heart Rhythm; 2017 Dec; 14(12):1826-1832. PubMed ID: 28917564
[TBL] [Abstract][Full Text] [Related]
3. Effects of Upgrade Versus De Novo Cardiac Resynchronization Therapy on Clinical Response and Long-Term Survival: Results from a Multicenter Study.
Vamos M; Erath JW; Bari Z; Vagany D; Linzbach SP; Burmistrava T; Israel CW; Duray GZ; Hohnloser SH
Circ Arrhythm Electrophysiol; 2017 Feb; 10(2):e004471. PubMed ID: 28202628
[TBL] [Abstract][Full Text] [Related]
4. Incidence, predictors, and procedural results of upgrade to resynchronization therapy: the RAFT upgrade substudy.
Essebag V; Joza J; Birnie DH; Sapp JL; Sterns LD; Philippon F; Yee R; Crystal E; Kus T; Rinne C; Healey JS; Sami M; Thibault B; Exner DV; Coutu B; Simpson CS; Wulffhart Z; Yetisir E; Wells G; Tang AS
Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):152-8. PubMed ID: 25417892
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes after upgrading from pacemakers to cardiac resynchronization therapy.
Leyva F; Zegard A; Patel K; Panting J; Marshall H; Qiu T
Pacing Clin Electrophysiol; 2018 Mar; 41(3):290-298. PubMed ID: 29369371
[TBL] [Abstract][Full Text] [Related]
6. Complications associated with cardiac resynchronization therapy upgrades versus de novo implantations.
Sidhu BS; Gould J; Sieniewicz BJ; Porter B; Rinaldi CA
Expert Rev Cardiovasc Ther; 2018 Aug; 16(8):607-615. PubMed ID: 29985076
[TBL] [Abstract][Full Text] [Related]
7. The European Cardiac Resynchronization Therapy Survey: comparison of outcomes between de novo cardiac resynchronization therapy implantations and upgrades.
Bogale N; Witte K; Priori S; Cleland J; Auricchio A; Gadler F; Gitt A; Limbourg T; Linde C; Dickstein K;
Eur J Heart Fail; 2011 Sep; 13(9):974-83. PubMed ID: 21771823
[TBL] [Abstract][Full Text] [Related]
8. Comparative Analysis of Procedural Outcomes and Complications Between De Novo and Upgraded Cardiac Resynchronization Therapy.
Nemer DM; Patel DR; Madden RA; Wilkoff BL; Rickard JW; Tarakji KG; Varma N; Hussein AA; Wazni OM; Kanj M; Baranowski B; Cantillon DJ
JACC Clin Electrophysiol; 2021 Jan; 7(1):62-72. PubMed ID: 33478714
[TBL] [Abstract][Full Text] [Related]
9. De novo implantation vs. upgrade cardiac resynchronization therapy: a systematic review and meta-analysis.
Kosztin A; Vamos M; Aradi D; Schwertner WR; Kovacs A; Nagy KV; Zima E; Geller L; Duray GZ; Kutyifa V; Merkely B
Heart Fail Rev; 2018 Jan; 23(1):15-26. PubMed ID: 29047028
[TBL] [Abstract][Full Text] [Related]
10. Comparison of De Novo versus Upgrade Cardiac Resynchronization Therapy; Focused on the Upgrade for Pacing-Induced Cardiomyopathy.
Gwag HB; Chun KJ; Hwang JK; Park KM; On YK; Kim JS; Park SJ
Yonsei Med J; 2017 Jul; 58(4):703-709. PubMed ID: 28540981
[TBL] [Abstract][Full Text] [Related]
11. Frequency of in-hospital adverse outcomes and cost utilization associated with cardiac resynchronization therapy defibrillator implantation in the United States.
Patel N; Viles-Gonzalez J; Agnihotri K; Arora S; Patel NJ; Aneja E; Shah M; Badheka AO; Pothineni NV; Kancharla K; Mulpuru S; Noseworthy PA; Kusumoto F; Cha YM; Deshmukh AJ
J Cardiovasc Electrophysiol; 2018 Oct; 29(10):1425-1435. PubMed ID: 30016005
[TBL] [Abstract][Full Text] [Related]
12. Long-term survival following upgrade compared with de novo cardiac resynchronization therapy implantation: a single-centre, high-volume experience.
Schwertner WR; Behon A; Merkel ED; Tokodi M; Kovács A; Zima E; Osztheimer I; Molnár L; Király Á; Papp R; Gellér L; Kuthi L; Veres B; Kosztin A; Merkely B
Europace; 2021 Aug; 23(8):1310-1318. PubMed ID: 34037220
[TBL] [Abstract][Full Text] [Related]
13. Cardiac Resynchronization Therapy: US Trends and Disparities in Utilization and Outcomes.
Sridhar AR; Yarlagadda V; Parasa S; Reddy YM; Patel D; Lakkireddy D; Wilkoff BL; Dawn B
Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):e003108. PubMed ID: 26921376
[TBL] [Abstract][Full Text] [Related]
14. Utilization and in-hospital complications of cardiac resynchronization therapy: trends in the United States from 2003 to 2013.
Hosseini SM; Moazzami K; Rozen G; Vaid J; Saleh A; Heist KE; Vangel M; Ruskin JN
Eur Heart J; 2017 Jul; 38(27):2122-2128. PubMed ID: 28329322
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome after upgrade to cardiac resynchronization therapy: A propensity score-matched analysis.
Trenson S; Voros G; Martens P; Ingelaere S; Betschart P; Voigt JU; Dupont M; Breitenstein A; Steffel J; Willems R; Ruschitzka F; Mullens W; Winnik S; Vandenberk B
Eur J Heart Fail; 2024 Feb; 26(2):511-520. PubMed ID: 37905357
[TBL] [Abstract][Full Text] [Related]
16. Comparison of
Zandi Z; Eslami M; Kamali F; Teimouri-Jervekani Z; Taherpour M; Mollazadeh R; Haghjoo M; Fazelifar AF; Alizadeh A; Madadi S; Hosseini Selki Sar S; Emkanjoo Z
Acta Cardiol; 2024 May; 79(3):338-343. PubMed ID: 38032242
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes of upgrade to versus de novo cardiac resynchronization therapy in mild heart failure patients with atrioventricular block.
Kanai M; Yagishita D; Shoda M; Ejima K; Hagiwara N
J Cardiol; 2022 Jan; 79(1):6-14. PubMed ID: 34426046
[TBL] [Abstract][Full Text] [Related]
18. Upgrades from a previous device compared to de novo cardiac resynchronization therapy in the European Society of Cardiology CRT Survey II.
Linde CM; Normand C; Bogale N; Auricchio A; Sterlinski M; Marinskis G; Sticherling C; Bulava A; Pérez ÓC; Maass AH; Witte KK; Rekvava R; Abdelali S; Dickstein K
Eur J Heart Fail; 2018 Oct; 20(10):1457-1468. PubMed ID: 29806208
[TBL] [Abstract][Full Text] [Related]
19. Comparison of
Stassen J; Scherrenberg M; Dilling-Boer D; Vijgen J; Koopman P; Schurmans J; Herbots L; Verwerft J; Schroyens M; Timmermans P
Acta Cardiol; 2021 Nov; 76(9):993-1000. PubMed ID: 33432875
[TBL] [Abstract][Full Text] [Related]
20. Upgrade and de novo cardiac resynchronization therapy: impact of paced or intrinsic QRS morphology on outcomes and survival.
Wokhlu A; Rea RF; Asirvatham SJ; Webster T; Brooke K; Hodge DO; Wiste HJ; Dong Y; Hayes DL; Cha YM
Heart Rhythm; 2009 Oct; 6(10):1439-47. PubMed ID: 19717348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
